For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Sequenom, Inc.

USPTO Granted Patents = 190

% Expired Patents = 19.5

CIPO Patents = 13

EPO Patents = 81

Trademarks = 6

Forward Citations = 9,528

Loading Chart...

Loading Chart...

131 inventors (with patents filed for the assignee):

Cosmin Deciu (35 out of 36 patents)

Mathias Ehrich (34 out of 38 patents)

Charles Cantor (28 out of 101 patents)

4. Hubert Köster (25 out of 26 patents)

5. Dirk Johannes Van Den Boom (21 out of 33 patents)

6. Zeljko Dzakula (21 out of 24 patents)

7. Sung Kyun Kim (17 out of 17 patents)

8. Andreas Braun (17 out of 17 patents)

9. Daniel P Little (15 out of 16 patents)

10. Hubert Koster (15 out of 17 patents)

11. Hubert Köster (12 out of 18 patents)

12. Amin R Mazloom (11 out of 15 patents)

13. Taylor Jacob Jensen (10 out of 11 patents)

14. Franz Hillenkamp (9 out of 12 patents)

15. Christian Jurinke (8 out of 8 patents)

Core Competencies:

Non-Invasive Testing

Fetal Nucleic Acid

Genetic Variations

Methylation Enrichment

Aneuploidy Detection

Nucleic Acid Analysis

Copy Number Alterations

Biological Molecules

Sequence Read Quantification

Solid Supports

Genetic Mosaicism

Polymorphic Markers

190 patents: Sort by Forward Citations

1. 12706175 - Methods and processes for non-invasive assessment of genetic variations (2026-08-11),

2. 12637714 - METHODS, AND SYSTEMS TO DETECT TRANSPLANT REJECTION (2026-05-26),

3. 12630865 - PRODUCTS AND PROCESSES FOR MULTIPLEX NUCLEIC ACID IDENTIFICATION (2026-05-19),

4. 12534758 - Methods and processes for non-invasive assessment of genetic variations (2026-01-27),

5. 12480159 - Compositions containing identifier sequences on solid supports for nucleic acid sequence analysis (2025-11-25),

6. 12437838 - Methods and processes for non-invasive analysis of cell-free fetal nucleic acid according to sequence read quantifications for chromosomes 13, 18, and 21 (2025-10-07),

7. 12421550 - Methods and processes for assessment of genetic mosaicism (2025-09-23),

8. 12410475 - Methods and processes for non-invasive assessment of genetic variations (2025-09-09),

9. 12400736 - Methods and processes for non-invasive estimation of fetal fraction (2025-08-26),

10. 12198786 - Methods and processes for non-invasive assessment of genetic variations (2025-01-14),

11. 12176067 - Methods and processes for non-invasive assessment of genetic variations (2024-12-24),

12. 12112832 - Methods and processes for non-invasive assessment of genetic variations (2024-10-08),

13. 12077752 - Nucleic acid preparation compositions and methods (2024-09-03),

14. 12071654 - Capture probe-based library normalization (2024-08-27),

15. 11952569 - Methods and compositions for the extraction and amplification of nucleic acid from a sample (2024-04-09),

Sequenom, Inc. is a life sciences company committed to enabling healthier lives through the development of innovative and proprietary testing technologies. The company's focus is on providing genetic analysis solutions that improve patient care and treatment outcomes in various areas such as reproductive health, oncology, and infectious diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

190 Patents

#28 in San Diego, CA

#470 in California

#2,161 in US

#4,423 in the World

San Diego, CA, United States of America

Sequenom, Inc.

Forward Citations = 9,528

131 inventors:

Cosmin Deciu (35 out of 36 patents)

Mathias Ehrich (34 out of 38 patents)

Charles Cantor (28 out of 101 patents)

4. Hubert Köster (25 out of 26 patents)

5. Dirk Johannes Van Den Boom (21 out of 33 patents)

Please report any incorrect information to [email protected]

Loading…